Hepion Pharmaceuticals's total assets for Q3 2024 were $3.72M, a decrease of -38.19% from the previous quarter. HEPA total liabilities were $4.12M for the fiscal quarter, a 68.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.